Denosumab versus zoledronate for the treatment of low bone mineral density in male HIV-infected patients.

导出 LinkOut

翻译打印收藏纠错

作者： Polyzois,Makras ^[1] ; Panagiotis,Petrikkos ^[2] ; Athanasios D,Anastasilakis ^[3] ; Artemis,Kolynou ^[4] ; Angeliki,Katsarou ^[2] ; Olga,Tsachouridou ^[4] ; Symeon,Metallidis ^[5] ; Maria P,Yavropoulou ^[6]

作者单位： Department of Endocrinology and Diabetes and Department of Medical Research, 251 Hellenic Air Force & VA General Hospital, Athens, Greece. ^[1] 2nd Department of Internal Medicine, 251 Hellenic Air Force & VA General Hospital, Athens, Greece. ^[2] Department of Endocrinology, 424 General Military Hospital, Thessaloniki, Greece. ^[3] Department of Microbiology, Medical School, Aristotle University of Thessaloniki, Thessaloniki, Greece. ^[4] Infectious Diseases Unit, 1 Department of Internal Medicine, AHEPA University Hospital, Aristotle University of Thessaloniki, Medical School, Thessaloniki, Greece. ^[5] Endocrinology Unit, 1 Department of Propedeutic and Internal Medicine, Medical School, National and Kapodistrian University of Athens, LAIKO General Hospital of Athens, Greece. ^[6]

关键词 Acute phase response Antiretroviral therapy (ART)Denosumab HIV Osteoporosis Zoledronate

DOI 10.1016/j.bonr.2021.101128

PMID 34541262

发布时间 2022-04-26

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览0

Bone reports

2021年15卷

101128页

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

Denosumab versus zoledronate for the treatment of low bone mineral density in male HIV-infected patients.

Bone reports

相似文献

Bone reports

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Denosumab versus zoledronate for the treatment of low bone mineral density in male HIV-infected patients.

Bone reports

相似文献

Bone reports

相关期刊

检索历史清除